Corcept Therapeutics (CORT) News Today $67.43 -1.19 (-1.73%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Russell Investments Group Ltd. Purchases 21,281 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Russell Investments Group Ltd. raised its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 11.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 202,504 shares of the biotechnology company's stock after acquirinApril 14 at 4:30 AM | marketbeat.comAviva PLC Cuts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Aviva PLC lowered its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 36.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,956 shares of the biotechnology company'April 14 at 4:22 AM | marketbeat.comLPL Financial LLC Grows Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)LPL Financial LLC lifted its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 47.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,682 shares of the biotechnology company'April 14 at 3:22 AM | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Receives $143.25 Consensus Price Target from AnalystsApril 14 at 1:46 AM | americanbankingnews.comAlliancebernstein L.P. Cuts Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Alliancebernstein L.P. reduced its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 8.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 170,869 shares of the biotechnoApril 13 at 4:19 AM | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by AnalystsShares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) have earned an average rating of "Buy" from the five research firms that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 1 year price objectivApril 13 at 3:13 AM | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Geode Capital Management LLCGeode Capital Management LLC lowered its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 13.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,068,175 shares of the biotechnology company's stock after sellApril 12 at 4:40 AM | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Trading Down 5.7% - Here's What HappenedCorcept Therapeutics (NASDAQ:CORT) Shares Down 5.7% - Here's WhyApril 11 at 12:55 PM | marketbeat.comShelton Capital Management Sells 10,867 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Shelton Capital Management reduced its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 7.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 128,914 shares of the biotechnology companApril 11 at 6:18 AM | marketbeat.comCerity Partners LLC Has $30.60 Million Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Cerity Partners LLC reduced its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 0.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 607,946 shares of the bioteApril 11 at 5:52 AM | marketbeat.comRenaissance Technologies LLC Has $312.35 Million Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Renaissance Technologies LLC lowered its position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 4.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,198,602 sharesApril 10, 2025 | marketbeat.com3 Biopharmaceutical Stocks Bucking the Sell-Off (CORT)Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.April 10, 2025 | marketbeat.comCorcept Therapeutics (NasdaqCM:CORT) Rises 36% in Last QuarterApril 9, 2025 | finance.yahoo.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Headlands Technologies LLCHeadlands Technologies LLC trimmed its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 84.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,117 shares of the biotechnologApril 9, 2025 | marketbeat.comFranklin Resources Inc. Raises Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)Franklin Resources Inc. increased its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 12.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 273,974 shares of the biotechnology company'sApril 9, 2025 | marketbeat.comCorcept Therapeutics initiates trial of Phase 2 trial BELLAApril 8, 2025 | markets.businessinsider.comPitcairn Co. Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Pitcairn Co. bought a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 4,138 shares of the biotechnology company's stock, valued at approximately $209,000. Other larApril 8, 2025 | marketbeat.com65,113 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Purchased by Trexquant Investment LPTrexquant Investment LP bought a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 65,113 shares of the biotechnologApril 8, 2025 | marketbeat.comZacks Research Issues Optimistic Estimate for CORT EarningsCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Investment analysts at Zacks Research upped their Q1 2026 EPS estimates for Corcept Therapeutics in a research note issued on Wednesday, April 2nd. Zacks Research analyst K. Das now forecasts that the biotechnology company will postApril 8, 2025 | marketbeat.comZacks Research Issues Positive Forecast for CORT EarningsApril 8, 2025 | americanbankingnews.comCorcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian CancerApril 7, 2025 | finance.yahoo.com10,905 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Bought by Atlas Capital Advisors Inc.Atlas Capital Advisors Inc. bought a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,905 shares of the biotechnologyApril 7, 2025 | marketbeat.comZacks Research Brokers Increase Earnings Estimates for CORTCorcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Equities research analysts at Zacks Research boosted their Q2 2026 earnings per share estimates for shares of Corcept Therapeutics in a research note issued on Wednesday, April 2nd. Zacks Research analyst K. Das now anticipates thatApril 6, 2025 | marketbeat.comIntegrated Quantitative Investments LLC Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Integrated Quantitative Investments LLC acquired a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investorApril 6, 2025 | marketbeat.comNorges Bank Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Norges Bank purchased a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 834,591 shares of the biotechnology company's stock, valued at approximately $April 6, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Price Target Raised to $131.00April 6, 2025 | americanbankingnews.comCorcept Therapeutics (NASDAQ:CORT) Given New $131.00 Price Target at Piper SandlerPiper Sandler upped their price target on Corcept Therapeutics from $128.00 to $131.00 and gave the company an "overweight" rating in a report on Thursday.April 5, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for CORT FY2026 Earnings?Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Stock analysts at HC Wainwright increased their FY2026 EPS estimates for Corcept Therapeutics in a research note issued to investors on Monday, March 31st. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology comApril 5, 2025 | marketbeat.comHC Wainwright Has Bullish Estimate for CORT FY2026 EarningsApril 5, 2025 | americanbankingnews.comCorcept Therapeutics (NASDAQ:CORT) Trading Down 7.9% - Time to Sell?Corcept Therapeutics (NASDAQ:CORT) Trading Down 7.9% - What's Next?April 4, 2025 | marketbeat.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) CEO Sells 35,102 Shares of StockApril 4, 2025 | insidertrades.comCorcept Therapeutics Incorporated (NASDAQ:CORT) CEO Joseph K. Belanoff Sells 35,102 SharesCorcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) CEO Joseph K. Belanoff sold 35,102 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $94.72, for a total transaction of $3,324,861.44. Following the completion of the transaction, the chief executive officer now directly owns 2,982,335 shares in the company, valued at approximately $282,486,771.20. The trade was a 1.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.April 4, 2025 | marketbeat.comSean Maduck Sells 100,000 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) StockCorcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) insider Sean Maduck sold 100,000 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $100.54, for a total transaction of $10,054,000.00. Following the transaction, the insider now owns 85,622 shares of the company's stock, valued at approximately $8,608,435.88. The trade was a 53.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.April 4, 2025 | marketbeat.com3,520 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Bought by New Age Alpha Advisors LLCNew Age Alpha Advisors LLC purchased a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 3,520 shares of the biotechnology comApril 4, 2025 | marketbeat.comCorcept Therapeutics price target raised to $131 from $128 at Piper SandlerApril 3, 2025 | markets.businessinsider.comClearbridge Investments LLC Has $24.26 Million Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Clearbridge Investments LLC reduced its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 9.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 481,389 shares of the biotechApril 3, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Holdings Decreased by Corebridge Financial Inc.Corebridge Financial Inc. decreased its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 7.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,488 shares of the biotechnolApril 3, 2025 | marketbeat.comVanguard Group Inc. Buys 109,294 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Vanguard Group Inc. raised its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 1.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,115,624 shares of the biotechnology company's stock afteApril 3, 2025 | marketbeat.comSei Investments Co. Purchases 54,521 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Sei Investments Co. increased its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 120.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,943 shares of the biApril 3, 2025 | marketbeat.comCorient Private Wealth LLC Purchases New Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)Corient Private Wealth LLC acquired a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 4,061 shares of the biotechnologyApril 3, 2025 | marketbeat.comBiotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & MoreApril 2, 2025 | msn.comCorcept Therapeutics Target of Unusually Large Options Trading (NASDAQ:CORT)Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors bought 3,892 put options on the stock. This is an increase of approximately 129% compared to the average daily volume of 1,699 put options.April 2, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Given New $142.00 Price Target at Canaccord Genuity GroupCanaccord Genuity Group lifted their price target on Corcept Therapeutics from $130.00 to $142.00 and gave the stock a "buy" rating in a research note on Tuesday.April 2, 2025 | marketbeat.comCorcept Therapeutics Stock (CORT) Rockets Up 100% After Groundbreaking Cancer Trial SuccessApril 2, 2025 | tipranks.comArrowstreet Capital Limited Partnership Buys 64,321 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)Arrowstreet Capital Limited Partnership raised its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 4.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,644,942 shares of the biotechnology company's stock after purchasingApril 2, 2025 | marketbeat.comPrudential Financial Inc. Lowers Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)Prudential Financial Inc. decreased its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 95,659 shares ofApril 2, 2025 | marketbeat.comCorcept Therapeutics: New PROC SOC Treatment Option With Relacorilant Data ReleaseApril 1, 2025 | seekingalpha.com2CORT : Corcept Therapeutics Unusual Options Activity For April 01April 1, 2025 | benzinga.comCorcept Therapeutics (NASDAQ:CORT) Given New $150.00 Price Target at Truist FinancialTruist Financial raised their price objective on shares of Corcept Therapeutics from $76.00 to $150.00 and gave the company a "buy" rating in a research report on Monday.April 1, 2025 | marketbeat.comCorcept Therapeutics (NASDAQ:CORT) Shares Gap Up on Analyst UpgradeCorcept Therapeutics (NASDAQ:CORT) Shares Gap Up on Analyst UpgradeApril 1, 2025 | marketbeat.com Remove Ads Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address CORT Media Mentions By Week CORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CORT News Sentiment▼1.040.86▲Average Medical News Sentiment CORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CORT Articles This Week▼248▲CORT Articles Average Week Remove Ads Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CORT) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CORT Stock Free CORT Stock Alerts